[1]
|
Sun, Y., Meng, F., Han, M., Zhang, X., Yu, L., Huang, H., et al. (2015) Epidemiology, Management, and Outcome of Invasive Fungal Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation in China: A Multicenter Prospective Observational Study. Biology of Blood and Marrow Transplantation, 21, 1117-1126.
https://doi.org/10.1016/j.bbmt.2015.03.018
|
[2]
|
Shi, J.-M., Pei, X.-Y., Luo, Y., Tan, Y.M., Tie, R.X., He, J.S., et al. (2015) Invasive Fungal Infection in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Single Center Experiences of 12 Years. Journal of Zhejiang University (Science B), 16, 796-804. https://doi.org/10.1631/jzus.B1500005
|
[3]
|
Nathan, S. and Ustun, C. (2019) Complications of Stem Cell Transplantation that Affect Infections in Stem Cell Transplant Recipients, with Analogies to Patients with Hematologic Malignancies. Infectious Disease Clinics of North America, 33, 331-359. https://doi.org/10.1016/j.idc.2019.01.002
|
[4]
|
Herity Leah, B., De la Cruz Oveimar, A. and Aziz May, T. (2021) Evaluation of a Primary Antifungal Prophylaxis Protocol for Preventing Invasive Mold Infections after Allogeneic Hematopoietic Stem Cell Transplantation. Journal of Oncology Pharmacy Practice. https://doi.org/10.1177/10781552211011221
|
[5]
|
Tacke, D., Buchheidt, D., Karthaus, M., Krause, S.W., Maschmeyer, G., Neumann, S., et al. (2014) Primary Prophylaxis of Invasive Fungal Infections in Patients with Haematologic Malignancies. 2014 Update of the Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology. Annals of Hematology, 93, 1449-1456. https://doi.org/10.1007/s00277-014-2108-y
|
[6]
|
邓颖, 颜小杭, 戴书华. 低剂量CT对肺部真菌感染患者的诊断价值[J]. 中华肺部疾病杂志(电子版), 2020, 13(5): 696-697.
|
[7]
|
姜尔烈, 韩明哲. 真菌感染标志物结合影像学证据在恶性血液病侵袭性真菌感染早期诊断中的价值[J]. 中华内科杂志, 2020, 59(10): 751-753.
|
[8]
|
杨艳红, 朱振龙. 肿瘤患者肺部侵袭性真菌感染特征及病理学特征分析[J]. 中国病原生物学杂志, 2018, 13(9): 1028-1031.
|
[9]
|
Maertens Johan, A., Girmenia, C., Brüggemann Roger, J., Duarte, R.F., Kibbler, C.C., Ljungman, P., et al. (2018) European Guidelines for Primary Antifungal Prophylaxis in Adult Haematology Patients: Summary of the Updated Recommendations from the European Conference on Infections in Leukaemia. The Journal of Antimicrobial Chemotherapy, 73, 3221-3230. https://doi.org/10.1093/jac/dky286
|
[10]
|
Dadwal, S.S., Hohl, T.M., Fisher, C.E., Boeckh, M., Papanicolaou, G., Carpenter, P.A., et al. (2021) American Society of Transplantation and Cellular Therapy Series, 2: Management and Prevention of Aspergillosis in Hematopoietic Cell Transplantation Recipients. Transplantation and Cellular Therapy, 27, 201-211.
https://doi.org/10.1016/j.jtct.2020.10.003
|
[11]
|
Girmenia, C., Barosi, G., Piciocchi, A., Arcese, W., Aversa, F., Bacigalupo, A., et al. (2014) Primary Prophylaxis of Invasive Fungal Diseases in Allogeneic Stem Cell Transplantation: Revised Recommendations from a Consensus Process by Gruppo Italiano Trapianto Midollo Osseo (GITMO). Biology of Blood and Marrow Transplantation, 20, 1080-1088. https://doi.org/10.1016/j.bbmt.2014.02.018
|
[12]
|
Epstein, D.J., Seo, S.K., Brown, J.M. and Papanicolaou, G.A. (2018) Echinocandin Prophylaxis in Patients Undergoing Haematopoietic Cell Transplantation and Other Treatments for Haematological Malignancies. The Journal of Antimicrobial Chemotherapy, 73, i60-i72. https://doi.org/10.1093/jac/dkx450
|
[13]
|
普文申, 陶冶. 他克莫司、环孢素与三唑类抗真菌药的代谢及药物相互作用[J]. 肾脏病与透析肾移植杂志, 2019, 28(1): 63-67.
|
[14]
|
许向华, 夏初, 黄怡. 棘白菌素在侵袭性肺真菌病预防和治疗中的作用[J]. 临床内科杂志, 2020, 37(8): 598-600.
|
[15]
|
韩晓燕, 宋亚丽, 白埔, 等. 抗真菌药物的系统分类、耐药机制及新药研发进展[J]. 中国现代应用药学, 2019, 36(11): 1430-1436.
|
[16]
|
Wang, J.-F., Xue, Y., Zhu, X.-B. and Fan, H. (2015) Efficacy and Safety of Echinocandins versus Triazoles for the Prophylaxis and Treatment of Fungal Infections: A Meta-Analysis of RCTs. European Journal of Clinical Microbiology & Infectious Diseases, 34, 651-659. https://doi.org/10.1007/s10096-014-2287-4
|
[17]
|
Dvorak, C.C., Fisher, B.T., Esbenshade, A.J., Nieder, M.L., Alexander, S., Steinbach, W.J., et al. (2021) A Randomized Trial of Caspofungin vs Triazoles Prophylaxis for Invasive Fungal Disease in Pediatric Allogeneic Hematopoietic Cell Transplant. Journal of the Pediatric Infectious Diseases Society, 10, 417-425.
https://doi.org/10.1093/jpids/piaa119
|
[18]
|
Natalia, M., Giulia, S., Roberto, S., Maestro, A. and Zanon, D. (2017) Comparison of Efficacy and Safety of Caspofungin versus Micafungin in Pediatric Allogeneic Stem Cell Transplant Recipients: A Retrospective Analysis. Advances in Therapy, 34, 1184-1199. https://doi.org/10.1007/s12325-017-0534-7
|
[19]
|
Mariotti, J., De Philippis, C., Bramanti, S., Sarina, B., Tordato, F., Pocaterra, D., et al. (2019) Caspofungin for Primary Antifungal Prophylaxis after T-Cell-Replete Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide. European Journal of Haematology, 102, 357-367. https://doi.org/10.1111/ejh.13214
|
[20]
|
De Pauw, B., Walsh, T.J., Peter Donnelly, J., Stevens, D.A., Edwards, J.E., Calandra, T., et al. (2008) Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clinical Infectious Diseases, 46, 1813-1821. https://doi.org/10.1086/588660
|
[21]
|
中国医师协会血液科医师分会, 中国侵袭性真菌感染工作组. 血液病/恶性肿瘤患者侵袭性真菌病的诊断标准与治疗原则(第六次修订版) [J]. 中华内科杂志, 2020, 59(10): 754-763.
|
[22]
|
Bays, D.J. and Thompson, G.R. (2019) Fungal Infections of the Stem Cell Transplant Recipient and Hematologic Malignancy Patients. Infectious Disease Clinics of North America, 33, 545-566. https://doi.org/10.1016/j.idc.2019.02.006
|
[23]
|
Ullmann, A.J., Cornely, O.A., Donnelly, J.P., Viscoli, C., Arendrup, M.C., Arikan-Akdagli, S., et al. (2012) ESCMID Guideline for the Diagnosis and Management of Candida Diseases 2012: Developing European Guidelines in Clinical Microbiology and Infectious Diseases. Clinical Microbiology and Infection, 18, 53-67.
https://doi.org/10.1111/1469-0691.12041
|
[24]
|
郑珊珊, 郭智, 陈丽娜, 刘玄勇, 陈丽萍, 黄嘉谊, 等. 血液肿瘤患者侵袭性真菌病经验治疗与诊断驱动治疗的对比研究[J]. 国际肿瘤学杂志, 2019, 46(7): 410-414.
|
[25]
|
Herbrecht, R., Maertens, J., Baila, L., Aoun, M., Heinz, W., Martino, R., et al. (2010) Caspofungin First-Line Therapy for Invasive Aspergillosis in Allogeneic Hematopoietic Stem Cell Transplant Patients: An European Organization for Research and Treatment of Cancer Study. Bone Marrow Transplantation, 45, 1227-1233.
https://doi.org/10.1038/bmt.2009.334
|
[26]
|
Safdar, A., Rodriguez, G., Zuniga, J., Al Akhrass, F. and Pande, A. (2015) High-Dose Caspofungin as a Component of Combination Antifungal Therapy in 91 Patients with Neoplastic Diseases and Hematopoietic Stem Cell Transplantation: A Critical Review of Short-Term and Long-Term Adverse Events. Journal of Pharmacy Practice, 28, 175-182.
https://doi.org/10.1177/0897190013515927
|
[27]
|
Zhang, H. (2021) Bridging Antifungal Prophylaxis with Micafungin in Hematopoietic Stem Cell Transplantation: A Retrospective Analysis. Hematology, 26, 670-674. https://doi.org/10.1080/16078454.2021.1959982
|
[28]
|
Cushion, M.T. and Ashbaugh, A. (2021) The Long-Acting Echinocandin, Rezafungin, Prevents Pneumocystis Pneumonia and Eliminates Pneumocystis from the Lungs in Prophylaxis and Murine Treatment Models. Journal of Fungi, 7, Article No. 747. https://doi.org/10.3390/jof7090747
|
[29]
|
Wang, C.-H., Kan, L.-P., Lin, H.-A., Chang, F.Y., Wang, N.C., Lin, T.Y., et al. (2016) Clinical Efficacy and Safety of Primary Antifungal Prophylaxis with Posaconazole versus Fluconazole in Allogeneic Blood Hematopoietic Stem Cell Transplantation Recipients—A Retrospective Analysis of a Single Medical Center in Taiwan. Journal of Microbiology, Immunology and Infection, 49, 531-538. https://doi.org/10.1016/j.jmii.2014.07.009
|
[30]
|
Huang, X., Chen, H., Han, M., Zou, P., Wu, D., Lai, Y., et al. (2012) Multicenter, Randomized, Open-Label Study Comparing the Efficacy and Safety of Micafungin versus Itraconazole for Prophylaxis of Invasive Fungal Infections in Patients Undergoing Hematopoietic Stem Cell Transplant. Biology of Blood and Marrow Transplantation, 18, 1509-1516.
https://doi.org/10.1016/j.bbmt.2012.03.014
|
[31]
|
Park, S., Kim, K., Jang, J.H., Kim, S.J., Kim, W.S., Chung, D.R., et al. (2016) Randomized Trial of Micafungin versus Fluconazole as Prophylaxis against Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients. Journal of Infection, 73, 496-505. https://doi.org/10.1016/j.jinf.2016.06.011
|
[32]
|
Gao, L., Sun, Y., Meng, F., Han, M., Huang, H., Wu, D., et al. (2016) Antifungal Prophylaxis of Patients Undergoing Allogenetic Hematopoietic Stem Cell Transplantation in China: A Multicenter Prospective Observational Study. Journal of Hematology & Oncology, 9, Article No. 97. https://doi.org/10.1186/s13045-016-0305-y
|
[33]
|
Wingard, J.R., Carter, S.L, Walsh, T.J., Kurtzberg, J., Small, T.N., Baden, L.R., et al. (2010) Randomized, Double-Blind Trial of Fluconazole versus Voriconazole for Prevention of Invasive Fungal Infection after Allogeneic Hematopoietic Cell Transplantation. Blood, 116, 5111-5118. https://doi.org/10.1182/blood-2010-02-268151
|
[34]
|
El-Cheikh, J., Crocchiolo, R., Vai, A., Furst, S., Bramanti, S., Sarina, B., et al. (2015) Comparison of Three Distinct Prophylactic Agents against Invasive Fungal Infections in Patients Undergoing Haplo-Identical Hematopoietic Stem Cell Transplantation and Post-Transplant Cyclophosphamide. Mediterranean Journal of Hematology and Infectious Diseases, 7, Article ID: e2015048. https://doi.org/10.4084/mjhid.2015.048
|